Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Capital Work in Progress

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹306 Cr₹207 Cr₹493 Cr₹670 Cr₹372 Cr

What is the latest Capital Work in Progress ratio of MANKIND PHARMA ?

The latest Capital Work in Progress ratio of MANKIND PHARMA is ₹306 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹306 Cr
Mar2024₹207 Cr
Mar2023₹493 Cr
Mar2022₹670 Cr
Mar2021₹372 Cr

How is Capital Work in Progress of MANKIND PHARMA Trending?

Years Capital Work in Progress % Change
Mar2025 ₹306 Cr
47.82
Mar2024 ₹207 Cr
-58.01
Mar2023 ₹493 Cr
-26.38
Mar2022 ₹670 Cr
80.26
Mar2021 ₹372 Cr -

Compare Capital Work in Progress of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹91,160.7 Cr 1% 6.6% -1.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,879.0 Cr 1.5% 6.9% 13.1% Stock Analytics
DIVIS LABORATORIES ₹166,620.0 Cr -0.8% 1.7% 14% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,431.0 Cr 3.2% 9% 44.8% Stock Analytics
DR REDDYS LABORATORIES ₹110,070.0 Cr 1.1% 5% 16.4% Stock Analytics
CIPLA ₹107,051.0 Cr 0.3% -1.3% -9% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1%

6.6%

-1.4%

SENSEX

-5%

-9.6%

3.1%


You may also like the below Video Courses